Tg Therapeutics (TGTX) Other Non Operating Income (2012 - 2026)

Tg Therapeutics' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$9.2 million for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 354.04% year-over-year to -$9.2 million; the TTM figure through Mar 2026 stood at -$2.0 million (down 118.61% YoY), while the FY2025 annual figure was $10.8 million, up 40.3% from the prior year.
• Other Non Operating Income was -$9.2 million for Q1 2026 at Tg Therapeutics, down from $1.1 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.6 million in Q1 2025 to a low of -$9.2 million in Q1 2026.
• Historically, Other Non Operating Income has averaged $1.1 million across 5 years, with a median of $1.7 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income jumped 309.43% in 2025, then slumped 354.04% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at $1.9 million in 2022, then plunged by 53.89% to $890000.0 in 2023, then soared by 188.2% to $2.6 million in 2024, then sank by 55.87% to $1.1 million in 2025, then plunged by 908.57% to -$9.2 million in 2026.
• The last three Other Non Operating Income figures came in at -$9.2 million (Q1 2026), $1.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.